SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Journal of Psychopharmacology
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (24)
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Parrott, A. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Parrott, A. C.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Reviews

MDMA in humans: factors which affect the neuropsychobiological profiles of recreational ecstasy users, the integrative role of bioenergetic stress

Andy C. Parrott

Department of Psychology, University of Swansea, Swansea SA2 8PP, UK

Many recreational ecstasy/MDMA users display neuropsychobiological de.cits, whereas others remain problem free. This review will investigate some of the drug and non-drug factors which in.uence the occurrence of these de.cits. Acute and chronic MDMA usage are both important. Intensive use within a session is often associated with more problems. In term of lifetime usage, novice users generally remain unimpaired, whereas most heavy users report memory or other psychobiological problems which they attribute to ecstasy. These complaints are con.rmed by objective de.cits in working memory, attention, frontal-executive, and episodic memory tasks. Psychobiological de.cits include disturbed sleep, sexual dysfunction, reduced immuno-competence, and increased oxidative stress. Further MDMA-related factors which may contribute to these changes, include acute and chronic tolerance, and drug dependence. Around 90ñ95% of ecstasy/MDMA users also take cannabis, and this can independently contribute to the adverse neuropsychobiological pro.les; although in some situations the acute co-use of these two drugs may be interactive rather than additive, since cannabis has relaxant and hypothermic properties. Alcohol, nicotine, amphetamine, and other drugs, can also affect the psychobiological pro.les of ecstasy polydrug users in complex ways. Pure MDMA users are rare but they have been shown to display signi.cant neurocognitive de.cits. Psychiatric aspects are debated in the context of the diathesisstress model. Here the stressor of ecstasy polydrug drug use, interacts with various predisposition factors (genetic, neurochemical, personality), to determine the psychiatric outcome. Recreational MDMA is typically taken in hot and crowded dances/raves. Prolonged dancing, feeling hot, and raised body temperature, can also be associated with more psychobiological problems. This is consistent with the animal literature, where high ambient temperature and other metabolic stimulants boost the acute effects of MDMA, and cause greater serotonergic neurotoxicity. In conclusion, the neuropsychobiological effects of MDMA are modulated by a wide range of drug and non-drug factors. These multiple in.uences are integrated within a bioenergetic stress model, where factors which heighten acute metabolic distress lead to more neuropsychobiological problems.

Key Words: MDMA • ecstasy • cannabis • memory • cognition • mood • bioenergy • stress • temperature

Journal of Psychopharmacology, Vol. 20, No. 2, 147-163 (2006)
DOI: 10.1177/0269881106063268


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
J PsychopharmacolHome page
K Soar, A Parrott, and J Turner
Attributions for psychobiological changes in ecstasy/MDMA and other polydrug users
J Psychopharmacol, September 1, 2009; 23(7): 745 - 758.
[Abstract] [PDF]


Home page
J PsychopharmacolHome page
R. Carhart-Harris, D. Nutt, M Munafo, and S. Wilson
Current and former ecstasy users report different sleep to matched controls: a web-based questionnaire study
J Psychopharmacol, May 1, 2009; 23(3): 249 - 257.
[Abstract] [PDF]


Home page
J PsychopharmacolHome page
K. Kuypers, M. Wingen, and J. Ramaekers
Memory and mood during the night and in the morning after repeated evening doses of MDMA
J Psychopharmacol, November 1, 2008; 22(8): 895 - 903.
[Abstract] [PDF]


Home page
J PsychopharmacolHome page
A. C. Parrott, I. S. McGregor, T. M. C. Lee, A. B. Scholey, and M. J. Morgan
International conference on memory (ICOM-4), University of New South Wales, Sydney, Australia, 16 21 July 2006 Ecstasy/MDMA and Memory Symposium
J Psychopharmacol, November 1, 2007; 21(8): 895 - 897.
[PDF]


Home page
J PsychopharmacolHome page
A. C. Parrott
Ecstasy versus alcohol: Tolstoy and the variations of unhappiness
J Psychopharmacol, January 1, 2007; 21(1): 3 - 6.
[PDF]


Home page
J PsychopharmacolHome page
A. C. Parrott
Alcohol, ecstasy, Aldous Huxley's 'soma'
J Psychopharmacol, January 1, 2007; 21(1): 8 - 9.
[PDF]



Advertisement